PT-141

PT-141 (bremelanotide) nasal spray. One 10 ml bottle containing 20 mg; the supplied label states 240 mcg per spray. This is a separate presentation from the PT-141 10 mg lyophilized vial. Bremelanotide is a melanocortin receptor agonist. Published prescribing information for injectable bremelanotide does not establish dosing, efficacy or approval for this nasal formulation. Product-specific directions, storage and suitability must be confirmed with the manufacturer and a qualified healthcare professional. Reference: FDA, Vyleesi prescribing information (subcutaneous formulation): https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210557s002lbl.pdf